Stryker Corporation logo
Stryker Corporation (SYK)
Compare

Stryker Corporation (SYK) Quick Ratio (Acid-Test): 1.21

popular:market cap|pe ratio|revenue|price history|total return

Is Stryker Corporation’s quick ratio (acid-test) high or low?

Stryker Corporation's quick ratio (acid-test) of 1.21 is in line with its 5-year average of 1.20, around the middle of its 5-year range (0.97–1.47).

As of Wednesday, June 17, 2026. 4.35% below its 12-month average of 1.27.

Current Ratio|Debt to Equity|P/FCF Ratio|All Metrics

SYK Quick Ratio (Acid-Test) Chart

SYK Quick Ratio (Acid-Test)
1.21-8.33% 1Y
Zoom

SYK Average Quick Ratio (Acid-Test) Chart

SYK Current vs Average Quick Ratio (Acid-Test) Chart

SYK Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.21

QUICK RATIO (ACID-TEST) AVG TTM

1.27

QUICK RATIO (ACID-TEST) AVG 3Y

1.13

QUICK RATIO (ACID-TEST) AVG 5Y

1.20

QUICK RATIO (ACID-TEST) AVG 10Y

1.51

QUICK RATIO (ACID-TEST) AVG 15Y

1.87

QUICK RATIO (ACID-TEST) AVG 20Y

2.16

CURRENT VS TTM AVG

-4.35%

CURRENT VS 3Y AVG

+7.56%

CURRENT VS 5Y AVG

+0.83%

CURRENT VS 10Y AVG

-20.06%

CURRENT VS 15Y AVG

-35.22%

CURRENT VS 20Y AVG

-43.89%

SYK Competitors' Quick Ratio (Acid-Test)

NAMEMARKET CAPQUICK RATIO (ACID-TEST)TTM3Y5Y
Stryker Corporation (SYK)$119.06B1.211.271.131.20
Bristol-Myers Squibb Company (BMY)vs ›$114.38B1.141.151.191.27
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$113.82B2.462.413.313.62
CVS Health Corporation (CVS)vs ›$127.54B0.630.610.630.63
Danaher Corporation (DHR)vs ›$128.72B1.511.281.371.36
Medtronic plc (MDT)vs ›$104.05B0.001.481.571.68
Intuitive Surgical, Inc. (ISRG)vs ›$148.26B3.963.593.744.30
Pfizer Inc. (PFE)vs ›$148.76B0.870.900.870.95
HCA Healthcare, Inc. (HCA)vs ›$88.05B0.730.850.971.05
Elevance Health Inc. (ELV)vs ›$86.74B1.241.171.081.07

Liquidity Comparison

Quick Ratio

1.21

Excludes inventory

Current Ratio

1.89

Includes inventory

Stryker Corporation Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio = (Current Assets − Inventory) / Current Liabilities

The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Stryker Corporation Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Stryker Corporation (SYK)?
The quick ratio (acid-test) for SYK stock is 1.21.
Is Stryker Corporation's quick ratio (acid-test) high or low?
Stryker Corporation's quick ratio (acid-test) of 1.21 is in line with its 5-year average of 1.20, around the middle of its 5-year range (0.97–1.47).
What is the TTM average quick ratio (acid-test) for Stryker Corporation (SYK)?
The TTM average quick ratio (acid-test) for SYK stock is 1.27.
What is the 3Y average quick ratio (acid-test) for Stryker Corporation (SYK)?
The 3Y average quick ratio (acid-test) for SYK stock is 1.13.
What is the 5Y average quick ratio (acid-test) for Stryker Corporation (SYK)?
The 5Y average quick ratio (acid-test) for SYK stock is 1.20.
What is the 10Y average quick ratio (acid-test) for Stryker Corporation (SYK)?
The 10Y average quick ratio (acid-test) for SYK stock is 1.51.
What is the 15Y average quick ratio (acid-test) for Stryker Corporation (SYK)?
The 15Y average quick ratio (acid-test) for SYK stock is 1.87.
What is the 20Y average quick ratio (acid-test) for Stryker Corporation (SYK)?
The 20Y average quick ratio (acid-test) for SYK stock is 2.16.

Stryker Corporation Quick Ratio (Acid-Test) History

DATEQUICK RATIO (ACID-TEST)
2025-12-311.21
2024-12-311.32
2023-12-310.97
2022-12-311.00
2021-12-311.47
2020-12-311.23
2019-12-311.84
2018-12-311.41
2017-12-311.68
2016-12-312.28
2015-12-312.24
2014-12-311.81
2013-12-312.60
2012-12-313.73
2011-12-313.23
2010-12-314.07
2009-12-313.41
2008-12-312.75
2007-12-313.08
2006-12-312.11
2005-12-311.85
2004-12-311.43
2003-12-311.09
2002-12-311.02
2001-12-311.11
2000-12-310.98
1999-12-311.08
1998-12-311.08
1997-12-312.05
1996-12-312.49

Related Metrics

Current RatioDebt to EquityP/FCF RatioAll Metrics

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI
53,000 employees
www.stryker.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo
View full financials